Atezolizumab
Roche
[]
immunotherapy in first line for patients with poor performance status and/or elderly! great data presented by dr lee at esmo ! 
I am Executive Director at the  Center for Thoracic Oncology at Mount Sinai Hospital , NYC and Professor of Medicine at Icahn Medical School at Mount Sinai, NY